{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:21:42Z","timestamp":1777929702606,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T00:00:00Z","timestamp":1239926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T00:00:00Z","timestamp":1239926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"abstract":"<jats:p>Es wird \u00fcber 134 Patienten mit malignen Tumor en des Nasopharynx (Epipharynx) berichtet. Darlegung der Behandlungsergebnisse un-ter Beriicksichtigung der Histologie, der Stadieneinteilung und der applizierten Tumordosis. Die Plattenepithelkarzinome des Nasopharynx weisen im Vergleich zu den strahlensensibleren Tumoren die schlechtere \u00dcberlebensziffer auf. Patienten mit Tumoren geringe-rer Ausdehnung lebten erwartungsgem\u00e4\u00df l\u00e4nger als solche in fort-ges\u00e7hrittenen Stadien. Sowohl bei den Plattenepithelkarzinomen als auch bei den strahlensensibleren Tumoren wurden bessere \u00dcber-lebensergebnisse bei Dosen \u00fcber 5000 Rad erzielt. Der Wert einer Kombinationsbehandlung mit Hyperthermie und antineoplastischer Chemotherapie wird diskutiert.<\/jats:p>","DOI":"10.1159\/000214446","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T11:36:39Z","timestamp":1240227399000},"page":"1-4","source":"Crossref","is-referenced-by-count":1,"title":["Ergebnisse der Strahlentherapie bei malignen Epipharynxtumoren aus den Jahren 1953\u20131977"],"prefix":"10.1159","author":[{"given":"C.","family":"Wieland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hymmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,4,17]]},"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/214446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000214446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:48:39Z","timestamp":1777679319000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000214446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,17]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000214446","archive":["Portico"],"relation":{},"ISSN":["0378-584X","1423-0240"],"issn-type":[{"value":"0378-584X","type":"print"},{"value":"1423-0240","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,17]]}}}